Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Patient Preferences Regarding Incidental Genomic Findings Discovered During Tumor Profiling

Cancer

Cancer Research

Oncology

2016

English

Healthcare Use After Screening for Lung Cancer

English

Can We Predict Who Lives Long With Ovarian Cancer?

English

Elevated Risk of Human Papillomavirus-Related Second Cancers in Survivors of Anal Canal Cancer

English

Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008

English

Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin With Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma

English

Identification of Accrual Barriers Onto Breast Cancer Prevention Clinical Trials

English

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

English

Estimating Global Treatment Toxicity Burden From Adverse-Event Data

English

Implementation of the National Breast and Cervical Cancer Early Detection Program: The Beginning

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Patient Preferences Regarding Incidental Genomic Findings Discovered During Tumor Profiling

Healthcare Use After Screening for Lung Cancer

Can We Predict Who Lives Long With Ovarian Cancer?

Elevated Risk of Human Papillomavirus-Related Second Cancers in Survivors of Anal Canal Cancer

Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008

Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin With Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma

Identification of Accrual Barriers Onto Breast Cancer Prevention Clinical Trials

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

Estimating Global Treatment Toxicity Burden From Adverse-Event Data

Implementation of the National Breast and Cervical Cancer Early Detection Program: The Beginning